首页> 外文OA文献 >A matched group study of triple negative versus HER-2 positive (irrespective of hormonal status) breast cancer: two subtypes with high-risk features and poor outcome

【2h】

A matched group study of triple negative versus HER-2 positive (irrespective of hormonal status) breast cancer: two subtypes with high-risk features and poor outcome

机译：一项三阴性与HER-2阳性（不论激素状态如何）乳腺癌的配对研究：两种亚型，具有高风险特征和不良预后

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Zekri, J M; Ibrahim, E; Ben Sadiq, B; Al-Gahmi, AM; Zeeneldin, AA; Elkhodary, TR; Gaballa, HE; Fawzy, EE; Elsayed, ME; Bahadur, Y; Awadalla, S; Alzahran, MS;
展开▼
作者单位

展开▼
年度 100
总页数
原文格式 PDF
正文语种 {"code":"en","name":"English","id":9}
中图分类

相似文献

外文文献
中文文献
专利

1. A matched group study of triple negative versus HER-2 positive (irrespective of hormonal status) breast cancer: two subtypes with high risk features and poor outcome [J] . JM Zekri, E Ibrahim, BB Sadiq, Ecancermedicalscience . 2010,第2014期

机译：三重阴性与HER-2阳性（不论激素状态如何）乳腺癌的配对研究：两种具有高风险特征和不良预后的亚型
2. Triple-Negative versus Non-Triple-Negative Breast Cancers in High-Risk Women: Phenotype Features and Survival from the HIBCRIT-1 MRI-Including Screening Study [J] . Podo Franca, Santoro Filippo, Di Leo Giovanni, Clinical cancer research: an official journal of the American Association for Cancer Research . 2016,第4期

机译：高危女性的三阴性与非三阴性乳腺癌：表型特征和生存从HIBCRIT-1 MRI包括筛选研究。
3. Triple-Negative versus Non-Triple-Negative Breast Cancers in High-Risk Women: Phenotype Features and Survival from the HIBCRIT-1 MRI-Including Screening Study [J] . Podo Franca, Santoro Filippo, Di Leo Giovanni, Clinical cancer research: an official journal of the American Association for Cancer Research . 2016,第4期

机译：高危女性的三阴性与非三阴性乳腺癌：表型特征和生存从HIBCRIT-1 MRI包括筛选研究。
4. Comparative proteomic analysis reveals an 11-protein signature that predicts clinical outcome in triple negative breast cancer [C] . Ning Qing Liu, Tommaso De Marchi, Annemieke M. Timmermans, American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2013

机译：比较蛋白质组学分析显示了11蛋白签名，其预测三重阴性乳腺癌中的临床结果
5. Preclinical exploration of novel small molecules as anticancer agents in triple-negative and HER2/neu-positive breast cancers. [D] . Weng, Shu-Chuan. 2008

机译：在三阴性和HER2 / neu阳性乳腺癌中作为抗癌药的新型小分子的临床前探索。
6. A matched group study of triple negative versus HER-2 positive (irrespective of hormonal status) breast cancer: two subtypes with high-risk features and poor outcome [O] . J M Zekri, E Ibrahim, B Ben Sadiq, 2010

机译：一项三阴性与HER-2阳性（不论激素状态如何）乳腺癌的配对研究：两种亚型具有高风险特征和不良预后
7. Triple-Negative versus Non–Triple-Negative Breast Cancers in High-Risk Women: Phenotype Features and Survival from the HIBCRIT-1 MRI-Including Screening Study [O] . Franca Podo, Filippo Santoro, Giovanni Di Leo, 2015

机译：高风险女性的三阴性与非三重阴性乳腺癌：Hibcrit-1 MRI的表型特征和生存 - 包括筛选研究

A matched group study of triple negative versus HER-2 positive (irrespective of hormonal status) breast cancer: two subtypes with high-risk features and poor outcome

著录项

引文网络

相似文献

相关主题

期刊订阅